After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RIGL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Rigel Pharmaceuticals is $515.88M. A total of 1.13 million shares were traded on the day, compared to an average of 626.87K shares.
In the most recent transaction, Schorno Dean L sold 2,036 shares of RIGL for 20.92 per share on Feb 04 ’25. After the transaction, the EVP & Chief Financial Officer now owns 58,969 company shares. In a previous transaction on Feb 05 ’25, Schorno Dean L sold 1,734 shares at 21.93 per share. RIGL shares that EVP & Chief Financial Officer owns now total 57,235.
Among the insiders who sold shares, Santos David A disposed of 2,125 shares on Feb 04 ’25 at a per-share price of $20.92. This resulted in the EVP, Chief Commercial Officer holding 53,500 shares of RIGL after the transaction. In another insider transaction, Santos David A sold 1,796 shares at $21.93 per share on Feb 05 ’25. Company shares held by the EVP, Chief Commercial Officer now total 51,704.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RIGL has a high of $43.72 and a low of $13.57.
As of this writing, RIGL has an earnings estimate of $0.79 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.08 per share and a lower estimate of $0.08. The company reported an EPS of $0.7 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RIGL’s latest balance sheet shows that the firm has $124.97M in Cash & Short Term Investments as of fiscal 2021. There were $30.57M in debt and $63.55M in liabilities at the time. Its Book Value Per Share was $4.57, while its Total Shareholder’s Equity was $30.37M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RIGL is Buy with a score of 3.67.
